NCT04546399 2026-06-12A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Phase 2 Recruiting461 enrolled